Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.
Identifieur interne : 000624 ( Main/Exploration ); précédent : 000623; suivant : 000625Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.
Auteurs : C. Alonso-Tarrés [Espagne] ; M L Villegas ; F J De Gispert ; M C Cortés-Lletget ; A. Rovira Plarromaní ; J. EtienneSource :
- European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [ 0934-9723 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Bactériémie (microbiologie), Bactériémie (traitement médicamenteux), Espagne (MeSH), Exotoxines (isolement et purification), Grippe humaine (diagnostic), Humains (MeSH), Infections communautaires (imagerie diagnostique), Infections communautaires (microbiologie), Infections communautaires (traitement médicamenteux), Leucocidine (isolement et purification), Mâle (MeSH), Pneumopathie à staphylocoques (microbiologie), Pneumopathie à staphylocoques (traitement médicamenteux), Résultat thérapeutique (MeSH), Staphylococcus aureus (isolement et purification), Tomodensitométrie (MeSH), Toxines bactériennes (MeSH).
- MESH :
- diagnostic : Grippe humaine.
- imagerie diagnostique : Infections communautaires.
- isolement et purification : Exotoxines, Leucocidine, Staphylococcus aureus.
- microbiologie : Bactériémie, Infections communautaires, Pneumopathie à staphylocoques.
- traitement médicamenteux : Bactériémie, Infections communautaires, Pneumopathie à staphylocoques.
- Adulte, Espagne, Humains, Mâle, Résultat thérapeutique, Tomodensitométrie, Toxines bactériennes.
English descriptors
- KwdEn :
- Adult (MeSH), Bacteremia (drug therapy), Bacteremia (microbiology), Bacterial Toxins (MeSH), Community-Acquired Infections (diagnostic imaging), Community-Acquired Infections (drug therapy), Community-Acquired Infections (microbiology), Exotoxins (isolation & purification), Humans (MeSH), Influenza, Human (diagnosis), Leukocidins (isolation & purification), Male (MeSH), Pneumonia, Staphylococcal (drug therapy), Pneumonia, Staphylococcal (microbiology), Spain (MeSH), Staphylococcus aureus (isolation & purification), Tomography, X-Ray Computed (MeSH), Treatment Outcome (MeSH).
- MESH :
- chemical , isolation & purification : Exotoxins, Leukocidins.
- chemical : Bacterial Toxins.
- diagnosis : Influenza, Human.
- diagnostic imaging : Community-Acquired Infections.
- drug therapy : Bacteremia, Community-Acquired Infections, Pneumonia, Staphylococcal.
- isolation & purification : Staphylococcus aureus.
- microbiology : Bacteremia, Community-Acquired Infections, Pneumonia, Staphylococcal.
- Adult, Humans, Male, Spain, Tomography, X-Ray Computed, Treatment Outcome.
Abstract
Reported here is what is believed to be the first case of community-acquired pneumonia caused by a Panton-Valentine leukocidin-producing strain of Staphylococcus aureus in Spain. Although lung infections caused by S. aureus strains carrying this powerful leukocidin gene are associated with necrotizing pneumonia and high mortality, the previously healthy 28-year-old male reported here experienced a good clinical course and recovery. It is thought that the hematogenous origin of the infection, the patient's lack of any previous respiratory viral infection and prompt initiation of therapy may explain the satisfactory evolution in this case.
DOI: 10.1007/s10096-005-0029-3
PubMed: 16328560
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.</title><author><name sortKey="Alonso Tarres, C" sort="Alonso Tarres, C" uniqKey="Alonso Tarres C" first="C" last="Alonso-Tarrés">C. Alonso-Tarrés</name><affiliation wicri:level="2"><nlm:affiliation>Servei d'Anàlisis Clíniques-Microbiologia, Hospital General de l'Hospitalet, CSI, Avinguda Josep Molins 29-41, L'Hospitalet de Llobregat, Barcelona, 08906, Spain. carlesmicro@gmail.com</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Servei d'Anàlisis Clíniques-Microbiologia, Hospital General de l'Hospitalet, CSI, Avinguda Josep Molins 29-41, L'Hospitalet de Llobregat, Barcelona, 08906</wicri:regionArea><placeName><region nuts="2" type="communauté">Catalogne</region></placeName></affiliation></author><author><name sortKey="Villegas, M L" sort="Villegas, M L" uniqKey="Villegas M" first="M L" last="Villegas">M L Villegas</name></author><author><name sortKey="De Gispert, F J" sort="De Gispert, F J" uniqKey="De Gispert F" first="F J" last="De Gispert">F J De Gispert</name></author><author><name sortKey="Cortes Lletget, M C" sort="Cortes Lletget, M C" uniqKey="Cortes Lletget M" first="M C" last="Cortés-Lletget">M C Cortés-Lletget</name></author><author><name sortKey="Rovira Plarromani, A" sort="Rovira Plarromani, A" uniqKey="Rovira Plarromani A" first="A" last="Rovira Plarromaní">A. Rovira Plarromaní</name></author><author><name sortKey="Etienne, J" sort="Etienne, J" uniqKey="Etienne J" first="J" last="Etienne">J. Etienne</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16328560</idno><idno type="pmid">16328560</idno><idno type="doi">10.1007/s10096-005-0029-3</idno><idno type="wicri:Area/Main/Corpus">00610</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00610</idno><idno type="wicri:Area/Main/Curation">000610</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000610</idno><idno type="wicri:Area/Main/Exploration">000610</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.</title><author><name sortKey="Alonso Tarres, C" sort="Alonso Tarres, C" uniqKey="Alonso Tarres C" first="C" last="Alonso-Tarrés">C. Alonso-Tarrés</name><affiliation wicri:level="2"><nlm:affiliation>Servei d'Anàlisis Clíniques-Microbiologia, Hospital General de l'Hospitalet, CSI, Avinguda Josep Molins 29-41, L'Hospitalet de Llobregat, Barcelona, 08906, Spain. carlesmicro@gmail.com</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Servei d'Anàlisis Clíniques-Microbiologia, Hospital General de l'Hospitalet, CSI, Avinguda Josep Molins 29-41, L'Hospitalet de Llobregat, Barcelona, 08906</wicri:regionArea><placeName><region nuts="2" type="communauté">Catalogne</region></placeName></affiliation></author><author><name sortKey="Villegas, M L" sort="Villegas, M L" uniqKey="Villegas M" first="M L" last="Villegas">M L Villegas</name></author><author><name sortKey="De Gispert, F J" sort="De Gispert, F J" uniqKey="De Gispert F" first="F J" last="De Gispert">F J De Gispert</name></author><author><name sortKey="Cortes Lletget, M C" sort="Cortes Lletget, M C" uniqKey="Cortes Lletget M" first="M C" last="Cortés-Lletget">M C Cortés-Lletget</name></author><author><name sortKey="Rovira Plarromani, A" sort="Rovira Plarromani, A" uniqKey="Rovira Plarromani A" first="A" last="Rovira Plarromaní">A. Rovira Plarromaní</name></author><author><name sortKey="Etienne, J" sort="Etienne, J" uniqKey="Etienne J" first="J" last="Etienne">J. Etienne</name></author></analytic><series><title level="j">European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</title><idno type="ISSN">0934-9723</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Bacteremia (drug therapy)</term><term>Bacteremia (microbiology)</term><term>Bacterial Toxins (MeSH)</term><term>Community-Acquired Infections (diagnostic imaging)</term><term>Community-Acquired Infections (drug therapy)</term><term>Community-Acquired Infections (microbiology)</term><term>Exotoxins (isolation & purification)</term><term>Humans (MeSH)</term><term>Influenza, Human (diagnosis)</term><term>Leukocidins (isolation & purification)</term><term>Male (MeSH)</term><term>Pneumonia, Staphylococcal (drug therapy)</term><term>Pneumonia, Staphylococcal (microbiology)</term><term>Spain (MeSH)</term><term>Staphylococcus aureus (isolation & purification)</term><term>Tomography, X-Ray Computed (MeSH)</term><term>Treatment Outcome (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Bactériémie (microbiologie)</term><term>Bactériémie (traitement médicamenteux)</term><term>Espagne (MeSH)</term><term>Exotoxines (isolement et purification)</term><term>Grippe humaine (diagnostic)</term><term>Humains (MeSH)</term><term>Infections communautaires (imagerie diagnostique)</term><term>Infections communautaires (microbiologie)</term><term>Infections communautaires (traitement médicamenteux)</term><term>Leucocidine (isolement et purification)</term><term>Mâle (MeSH)</term><term>Pneumopathie à staphylocoques (microbiologie)</term><term>Pneumopathie à staphylocoques (traitement médicamenteux)</term><term>Résultat thérapeutique (MeSH)</term><term>Staphylococcus aureus (isolement et purification)</term><term>Tomodensitométrie (MeSH)</term><term>Toxines bactériennes (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Exotoxins</term><term>Leukocidins</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Bacterial Toxins</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Community-Acquired Infections</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Bacteremia</term><term>Community-Acquired Infections</term><term>Pneumonia, Staphylococcal</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Infections communautaires</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Staphylococcus aureus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Exotoxines</term><term>Leucocidine</term><term>Staphylococcus aureus</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Bactériémie</term><term>Infections communautaires</term><term>Pneumopathie à staphylocoques</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Bacteremia</term><term>Community-Acquired Infections</term><term>Pneumonia, Staphylococcal</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Bactériémie</term><term>Infections communautaires</term><term>Pneumopathie à staphylocoques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Humans</term><term>Male</term><term>Spain</term><term>Tomography, X-Ray Computed</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Espagne</term><term>Humains</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Tomodensitométrie</term><term>Toxines bactériennes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Reported here is what is believed to be the first case of community-acquired pneumonia caused by a Panton-Valentine leukocidin-producing strain of Staphylococcus aureus in Spain. Although lung infections caused by S. aureus strains carrying this powerful leukocidin gene are associated with necrotizing pneumonia and high mortality, the previously healthy 28-year-old male reported here experienced a good clinical course and recovery. It is thought that the hematogenous origin of the infection, the patient's lack of any previous respiratory viral infection and prompt initiation of therapy may explain the satisfactory evolution in this case.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16328560</PMID><DateCompleted><Year>2006</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0934-9723</ISSN><JournalIssue CitedMedium="Print"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2005</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</Title><ISOAbbreviation>Eur. J. Clin. Microbiol. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.</ArticleTitle><Pagination><MedlinePgn>756-9</MedlinePgn></Pagination><Abstract><AbstractText>Reported here is what is believed to be the first case of community-acquired pneumonia caused by a Panton-Valentine leukocidin-producing strain of Staphylococcus aureus in Spain. Although lung infections caused by S. aureus strains carrying this powerful leukocidin gene are associated with necrotizing pneumonia and high mortality, the previously healthy 28-year-old male reported here experienced a good clinical course and recovery. It is thought that the hematogenous origin of the infection, the patient's lack of any previous respiratory viral infection and prompt initiation of therapy may explain the satisfactory evolution in this case.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alonso-Tarrés</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servei d'Anàlisis Clíniques-Microbiologia, Hospital General de l'Hospitalet, CSI, Avinguda Josep Molins 29-41, L'Hospitalet de Llobregat, Barcelona, 08906, Spain. carlesmicro@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villegas</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>de Gispert</LastName><ForeName>F J</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Cortés-Lletget</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Rovira Plarromaní</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Etienne</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA><NlmUniqueID>8804297</NlmUniqueID><ISSNLinking>0934-9723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001427">Bacterial Toxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005098">Exotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007956">Leukocidins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078284">Panton-Valentine leukocidin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="N">Bacteremia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001427" MajorTopicYN="N">Bacterial Toxins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005098" MajorTopicYN="N">Exotoxins</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007956" MajorTopicYN="N">Leukocidins</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011023" MajorTopicYN="N">Pneumonia, Staphylococcal</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>2</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16328560</ArticleId><ArticleId IdType="doi">10.1007/s10096-005-0029-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Infect Chemother. 2002 Mar;8(1):99-102</Citation><ArticleIdList><ArticleId IdType="pubmed">11957128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Dermatol Venereol. 1997;124(10 ):684-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9740863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ned Tijdschr Geneeskd. 2003 May 31;147(22):1076-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12814021</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1999 Nov;29(5):1128-32</Citation><ArticleIdList><ArticleId IdType="pubmed">10524952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2002 Mar 2;359(9308):753-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11888586</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Dec 10;290(22):2976-84</Citation><ArticleIdList><ArticleId IdType="pubmed">14665659</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):1-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15599784</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2005 Jan 1;40(1):100-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15614698</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1995 Oct;63(10):4121-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7558328</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Infect Dis. 2002;34(10):763-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12477329</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2001 Feb;39(2):728-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11158136</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2003 Aug;9(8):978-84</Citation><ArticleIdList><ArticleId IdType="pubmed">12967497</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2002 Feb;70(2):631-41</Citation><ArticleIdList><ArticleId IdType="pubmed">11796592</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Dermatol Venereol. 1997;124(10):740-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9740879</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagn Microbiol Infect Dis. 2004 Jul;49(3):157-62</Citation><ArticleIdList><ArticleId IdType="pubmed">15246504</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2005 Apr 7;352(14):1445-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15814880</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2003 Oct;29(10):1840-3</Citation><ArticleIdList><ArticleId IdType="pubmed">12904849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2004 Feb;42(2):825-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14766862</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1991 Oct;29(10):2240-4</Citation><ArticleIdList><ArticleId IdType="pubmed">1939577</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Catalogne</li></region></list><tree><noCountry><name sortKey="Cortes Lletget, M C" sort="Cortes Lletget, M C" uniqKey="Cortes Lletget M" first="M C" last="Cortés-Lletget">M C Cortés-Lletget</name><name sortKey="De Gispert, F J" sort="De Gispert, F J" uniqKey="De Gispert F" first="F J" last="De Gispert">F J De Gispert</name><name sortKey="Etienne, J" sort="Etienne, J" uniqKey="Etienne J" first="J" last="Etienne">J. Etienne</name><name sortKey="Rovira Plarromani, A" sort="Rovira Plarromani, A" uniqKey="Rovira Plarromani A" first="A" last="Rovira Plarromaní">A. Rovira Plarromaní</name><name sortKey="Villegas, M L" sort="Villegas, M L" uniqKey="Villegas M" first="M L" last="Villegas">M L Villegas</name></noCountry><country name="Espagne"><region name="Catalogne"><name sortKey="Alonso Tarres, C" sort="Alonso Tarres, C" uniqKey="Alonso Tarres C" first="C" last="Alonso-Tarrés">C. Alonso-Tarrés</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000624 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000624 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:16328560
|texte= Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16328560" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |